Subgroup analysis in RAISE: A randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression

1. Obermannová, R.
2. Van Cutsem, E.
3. Yoshino, T.
4. Bodoky, G.
5. Prausová, J.
6. Garcia-Carbonero, R.
7. Ciuleanu, T.
8. Garcia Alfonso, P.
9. Portnoy, D.
10. Cohn, A.
11. Yamazaki, K.
12. Clingan, P.
13. Lonardi, S.
14. Kim, T.W.
15. Yang, L.
16. Nasroulah, F.
17. Tabernero, J.